Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Medical device industry urges exemptions, warns tariffs could disrupt patient care
Summary
Industry witnesses told the Senate Finance Committee that broad tariffs on imported inputs would raise costs and risk supply disruptions for life‑saving medical devices; AdvaMed asked for targeted flexibility and a reciprocal 0‑for‑0 approach in negotiations.
Medical device makers told the Senate Finance Committee on May 14, 2025, that broad tariffs on imported inputs risk disrupting hospitals’ access to essential equipment and raising health‑care costs.
The medical technology trade group AdvaMed’s president and chief executive, Scott Whitaker, told the committee that “MedTech products are mandatory, not optional. They can mean the difference between life and death, which is why they're highly regulated as they should be.” He said up to 70% of medical technology used in the United States is already made domestically and that the industry supports about 3,000,000 jobs.
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
